Targeting cancer stem cells with ribosome-inactivating proteins: from molecular mechanisms to clinical translation.
INTRODUCTION Cancer stem cells (CSCs) are a rare but highly tumorigenic subpopulation that drives tumor initiation, therapeutic resistance, metastasis, and disease recurrence. Their intrinsic resistance to conventional therapies has prompted the development of targeted strategies capable of selectively eliminating CSCs...